Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001326732-25-000067
Filing Date
2025-07-31
Accepted
2025-07-31 19:02:34
Documents
1
Period of Report
2025-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1754002949.html 4  
1 FORM 4 wk-form4_1754002949.xml 4 3875
  Complete submission text file 0001326732-25-000067.txt   5293
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Issuer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 995 EL CAMPO DR. PASADENA CA 91107
Business Address
Deshaies Raymond Joseph (Reporting) CIK: 0002079360 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36182 | Film No.: 251173253